Jazz Pharmaceuticals (JAZZ) Net Margin (2010 - 2026)
Jazz Pharmaceuticals' (JAZZ) quarterly Net Margin came in at 27.42% in Q1 2026, up 3771.0% year-on-year from 0.71% in Q1 2025, and up 61.4% quarter-over-quarter from 16.99% in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Net Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Net Margin history runs 16 years deep, the most recent figure standing at 27.42% for Q1 2026.
- On a quarterly basis, Net Margin rose 3771.0% year-over-year to 27.42% in Q1 2026; TTM through Mar 2026 was 0.67%, a 1121.0% decrease from a year earlier, with the FY2025 full-year figure at 8.33%, down 2213.0% from the prior year.
- Net Margin climbed to 27.42% in Q1 2026 per JAZZ's latest filing, from 16.99% in the prior quarter.
- Across five years, Net Margin topped out at 27.42% in Q1 2026 and bottomed at 68.7% in Q2 2025.
- The 5-year median for Net Margin is 9.35% (2023), against an average of 3.66%.
- Across the five-year window, Net Margin surged 5248 bps in 2022 and tumbled 8517 bps in 2025, its largest moves.
- Year by year, Net Margin stood at 24.68% in 2022, then surged by 138 bps to 9.35% in 2023, then jumped by 88 bps to 17.57% in 2024, then dropped by 3 bps to 16.99% in 2025, then surged by 61 bps to 27.42% in 2026.
- Per Business Quant, the three latest JAZZ Net Margin figures stand at 27.42% (Q1 2026), 16.99% (Q4 2025), and 22.33% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | 27.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.42% |
| Dec 31, 2025 | 16.99% |
| Sep 30, 2025 | 22.33% |
| Jun 30, 2025 | -68.70% |
| Mar 31, 2025 | -10.29% |
| Dec 31, 2024 | 17.57% |
| Sep 30, 2024 | 20.41% |
| Jun 30, 2024 | 16.47% |
| Mar 31, 2024 | -1.62% |
| Dec 31, 2023 | 9.35% |
| Sep 30, 2023 | 15.09% |
| Jun 30, 2023 | 11.08% |
| Mar 31, 2023 | 7.89% |
| Dec 31, 2022 | -24.68% |
| Sep 30, 2022 | -1.82% |
| Jun 30, 2022 | 3.98% |
| Mar 31, 2022 | 0.71% |
| Dec 31, 2021 | -3.61% |
| Sep 30, 2021 | -5.91% |
| Jun 30, 2021 | -48.50% |